tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PYPD Stock Latest News

PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
Company AnnouncementsPolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
9d ago
6K
PYPD
PolyPid announces research, development collaboration with ImmunoGenesis
PremiumThe Fly
PolyPid announces research, development collaboration with ImmunoGenesis
9d ago
PYPD
PolyPid Faces Nasdaq Non-Compliance Challenge
PremiumCompany Announcements
PolyPid Faces Nasdaq Non-Compliance Challenge
21d ago
6K
PYPD
PolyPid receives noncompliance notification from Nasdaq
PremiumThe Fly
PolyPid receives noncompliance notification from Nasdaq
21d ago
PYPD
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress
PremiumCompany Announcements
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress
1M ago
PYPD
PolyPid Announces SHIELD II Trial Progress and Financials
PremiumCompany AnnouncementsPolyPid Announces SHIELD II Trial Progress and Financials
1M ago
6K
PYPD
PolyPid reports Q3 EPS ($1.22), consensus ($1.00)
Premium
The Fly
PolyPid reports Q3 EPS ($1.22), consensus ($1.00)
1M ago
PYPD
PolyPid sees runway into 1Q25
Premium
The Fly
PolyPid sees runway into 1Q25
1M ago
PYPD
PYPD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PYPD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
PYPD
PolyPid Announces $8.25 Million Share Sale Plan
PremiumCompany Announcements
PolyPid Announces $8.25 Million Share Sale Plan
1M ago
6K
PYPD
Craig-Hallum bullish on PolyPid, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on PolyPid, initiates with a Buy
2M ago
PYPD
PolyPid initiated with a Buy at Craig-Hallum
PremiumThe Fly
PolyPid initiated with a Buy at Craig-Hallum
2M ago
PYPD
PolyPid announces publication in IJS on Phase 3 SHIELD I trial of D-PLEX100
PremiumThe FlyPolyPid announces publication in IJS on Phase 3 SHIELD I trial of D-PLEX100
2M ago
PYPD
PolyPid Nears Completion of Key Phase 3 Trial
Premium
Company Announcements
PolyPid Nears Completion of Key Phase 3 Trial
3M ago
6K
PYPD
PolyPid enrolls last patient for planned unblinded interim analysis in SHIELD II
Premium
The Fly
PolyPid enrolls last patient for planned unblinded interim analysis in SHIELD II
3M ago
PYPD
PolyPid files to sell 3.91M ordinary shares for holders
PremiumThe Fly
PolyPid files to sell 3.91M ordinary shares for holders
4M ago
PYPD
PolyPid Reports Growth in Mid-Year Assets
PremiumCompany Announcements
PolyPid Reports Growth in Mid-Year Assets
4M ago
6K
PYPD
PolyPid Advances SHIELD II Trial with Solid Financing
PremiumCompany Announcements
PolyPid Advances SHIELD II Trial with Solid Financing
4M ago
6K
PYPD
PolyPid reports Q2 EPS ($1.25), consensus ($1.30)
PremiumThe Fly
PolyPid reports Q2 EPS ($1.25), consensus ($1.30)
4M ago
PYPD
PYPD Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPYPD Upcoming Earnings Report: What to Expect?
4M ago
PYPD
PolyPid Secures Funding, Extends Runway for D-PLEX100 Trial
Premium
Company Announcements
PolyPid Secures Funding, Extends Runway for D-PLEX100 Trial
5M ago
6K
PYPD
PolyPid announces private placement of up to $14M in proceeds
Premium
The Fly
PolyPid announces private placement of up to $14M in proceeds
5M ago
PYPD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >